A股異動 | 志邦家居連續兩日漲停 績後獲多家機構看好
格隆匯3月4日丨志邦家居(603801.SH)連續第二日漲停,現報25.76元,暫成交1.7億元,最新總市值57.5億元。志邦家居前日(2日)晚間公佈,2019年實現營業總收入29.66億元,同比增長21.92%;歸屬於上市公司股東的淨利潤3.31億元,同比增長21.30%;基本每股收益1.5071元。績後興業證券發研報指,志邦家居19Q4表現搶眼帶動全年收入、利潤雙超預期,預計公司20/21年實現歸母淨利潤3.66/4.20 億元,對應PE12.98x/11.32x。中泰證券亦指其四季度增長強勁,多渠道穩健推進,目前估值具備較高吸引力,予“買入”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.